Farringdon Capital’s RXO RXO Stock Holding History

Farringdon Capital’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,722	Closed	-$184K	–	627
2025 Q2	$184K	Buy	+11,722	New	+$178K	0.06%	404

Other funds holding RXO

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Farringdon Capital's RXO Position: Q3 2025 in Review

Farringdon Capital sold out of RXO (RXO) in Q3 2025, closing a stake of 11,722 shares — an estimated $184K sold.

Farringdon Capital first reported a position in RXO in Q2 2025 and held it in 1 quarter. The position peaked at $184K in Q2 2025. 265 funds tracked by Wall St. Rank hold RXO as of Q3 2025.

Farringdon Capital reported no remaining RXO position as of Q3 2025 after selling out during the quarter.
Farringdon Capital sold 11,722 RXO shares in Q3 2025, an estimated $184K.
Farringdon Capital first reported a position in RXO in Q2 2025 and held it in 1 quarter.
Farringdon Capital's RXO position peaked at $184K in Q2 2025.
265 funds tracked by Wall St. Rank held RXO as of Q3 2025.

Based on Farringdon Capital's 13F filing for Q3 2025, filed 13 Nov 2025.